Never miss a Delaware County story!
A public stock offering from Mineralys Therapeutics of Radnor netted $192 million for the company’s development of a new blood pressure drug candidate, lorundrostat…
Mineralys Therapeutics in Radnor is on its way to developing a drug that will selectively treat hypertension, writes Laura Brzyski for Philadelphia Magazine.
Mineralys Therapeutics…
Before we send you to this site, please subscribe to our daily newsletter.